First Header Logo Second Header Logo

Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.

Urieto JO, Liu T, Black JH, Cohen KA, Hall PD, Willingham MC, Pennell LK, Hogge DE, Kreitman RJ, Frankel AE. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials. Protein Expr Purif. 2004 Jan; 33(1):123-33.

View in: PubMed